Results 1 to 10 of about 110,018 (259)

Cardiovascular preventive role of thiazolidinedione in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention. [PDF]

open access: yesJ Diabetes Investig
Among patients with type 2 diabetes undergoing percutaneous coronary intervention, thiazolidinedione use was independently associated with a significantly reduced risk of a composite of myocardial infarction, stroke, and all‐cause death, notably without an increased risk of admission for heart failure. ABSTRACT Background Thiazolidinediones (TZD) are a
Kim J   +5 more
europepmc   +2 more sources

Use of a digital health solution after percutaneous coronary intervention: a randomised controlled trial. [PDF]

open access: yesFront Digit Health
Gudmundsson EF   +16 more
europepmc   +1 more source

Outcomes of Percutaneous Coronary Intervention Stratified by Body Mass Index. [PDF]

open access: yesCureus
Oletu H   +11 more
europepmc   +1 more source

Percutaneous Coronary Intervention and vascular access complications: A contemporary review. [PDF]

open access: yesNPJ Cardiovasc Health
Attachaipanich T   +6 more
europepmc   +1 more source

Percutaneous Coronary Intervention

open access: yesJournal of the American College of Cardiology, 2015
Rinfret, Stéphane   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy